No Data
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
Absci Started by Guggenheim at Buy on Pioneer Status in AI Drug Design
Absci Initiated at Buy by Guggenheim
Guggenheim Initiates Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $10
Is Absci (NASDAQ:ABSI) Using Debt In A Risky Way?
Black horse rises! AI startup receives support from OpenAI, only 6 months since its establishment.
①Chai Discovery, a biotechnology startup company that has been established for nearly half a year, raised nearly $300 million in the latest round of financing at a valuation of $1.5 billion; ②According to Chai, the company's developed AI basic model can predict the structure of biochemical molecules and reprogram their interactions, a process that is crucial for the development of new drugs.